ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities research analysts at HC Wainwright boosted their FY2027 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a note issued to investors on Thursday, August 7th. HC Wainwr…